Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by JOHNSON JOHN

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
XERSXeris Biopharma Holdings, Inc.JOHNSON JOHNDirectorMar 18, 2024Option Exercise$1.99215,600429,044751,412Mar 18, 2024, 05:32 PM
SBBPStrongbridge Biopharma plcJOHNSON JOHNChief Executive OfficerOct 01, 2021Option Exercise$2.06334,868689,828610,092Oct 05, 2021, 07:24 PM
SBBPStrongbridge Biopharma plcJOHNSON JOHNChief Executive OfficerJul 02, 2021Option Exercise$3.0850,867156,670944,960Jul 07, 2021, 05:01 PM
SBBPStrongbridge Biopharma plcJOHNSON JOHNChief Executive OfficerApr 08, 2021Option Exercise$2.6817,32546,431995,827Apr 09, 2021, 05:13 PM
PTLAPORTOLA PHARMACEUTICALS INCJOHNSON JOHNDirectorJul 02, 2020Option Exercise$18.0020,475368,5500Jul 02, 2020, 04:29 PM
SBBPStrongbridge Biopharma plcJOHNSON JOHNExecutive ChairmanMay 15, 2020Option Exercise$2.8615,34843,895207,152May 18, 2020, 04:51 PM
MLNTMELINTA THERAPEUTICS, INC. /NEW/JOHNSON JOHNChief Executive OfficerJun 27, 2019Sale$5.5713,00072,44137,400Jul 02, 2019, 09:09 PM
SCMPSucampo Pharmaceuticals, Inc.JOHNSON JOHNDirectorFeb 13, 2018Option Exercise$18.005,13092,3400Feb 13, 2018, 04:52 PM
DNDNDENDREON CORPJOHNSON JOHNPres & Chief Executive OfficerJul 03, 2014Option Exercise$2.2912,09027,6861,071,125Jul 08, 2014, 02:39 PM
CEMPCEMPRA, INC.JOHNSON JOHNDirectorMay 23, 2014Buy$9.1010,00090,98010,000May 28, 2014, 05:23 PM
DNDNDENDREON CORPJOHNSON JOHNPres & Chief Executive OfficerApr 03, 2014Option Exercise$2.939,45927,7151,083,215Apr 04, 2014, 06:12 PM
DNDNDENDREON CORPJOHNSON JOHNPres & Chief Executive OfficerFeb 10, 2014Option Exercise$2.8122,84364,1891,092,674Feb 12, 2014, 02:38 PM
DNDNDENDREON CORPJOHNSON JOHNPres & Chief Executive OfficerJan 03, 2014Option Exercise$3.0835,796110,2521,049,016Jan 07, 2014, 03:41 PM
DNDNDENDREON CORPJOHNSON JOHNPres & Chief Executive OfficerDec 31, 2013Option Exercise$2.9938,382114,762689,623Jan 03, 2014, 07:14 PM
DNDNDENDREON CORPJOHNSON JOHNChief Executive OfficerDec 31, 2012Option Exercise$5.2940,342213,409332,816Jan 02, 2013, 03:07 PM
SVNTSAVIENT PHARMACEUTICALS INCJOHNSON JOHNChief Executive OfficerJan 03, 2012Sale$2.3017,65040,595252,350Jan 04, 2012, 04:17 PM
SVNTSAVIENT PHARMACEUTICALS INCJOHNSON JOHNCEO & PresidentNov 21, 2011Buy$2.305,00011,500270,000Nov 22, 2011, 06:40 PM
SVNTSAVIENT PHARMACEUTICALS INCJOHNSON JOHNCEO & PresidentNov 18, 2011Buy$2.2810,00022,800265,000Nov 21, 2011, 12:06 PM
SVNTSAVIENT PHARMACEUTICALS INCJOHNSON JOHNCEO & PresidentNov 18, 2011Buy$2.361,0002,3604,000Nov 21, 2011, 12:06 PM
DNDNDENDREON CORPJOHNSON JOHNDirectorNov 04, 2011Buy$6.682,50016,68912,943Nov 07, 2011, 05:50 PM
SVNTSAVIENT PHARMACEUTICALS INCJOHNSON JOHNCEO & PresidentSep 14, 2011Buy$3.881,5005,8241,500Sep 16, 2011, 07:05 PM
SVNTSAVIENT PHARMACEUTICALS INCJOHNSON JOHNCEO & PresidentSep 16, 2011Buy$4.1025,000102,492255,000Sep 16, 2011, 07:05 PM
SVNTSAVIENT PHARMACEUTICALS INCJOHNSON JOHNCEO & PresidentSep 16, 2011Buy$4.091,5006,1353,000Sep 16, 2011, 07:05 PM
SVNTSAVIENT PHARMACEUTICALS INCJOHNSON JOHNChief Executive OfficerJan 31, 2011Option Exercise$9.23230,0002,122,900230,000Feb 02, 2011, 04:59 PM
SVNTSAVIENT PHARMACEUTICALS INCJOHNSON JOHNChief Executive OfficerJan 31, 2011Option Exercise$9.23230,0002,122,900230,000Feb 02, 2011, 04:59 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe